These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 26341629)

  • 1. Methylseleninic acid activates Keap1/Nrf2 pathway via up-regulating miR-200a in human oesophageal squamous cell carcinoma cells.
    Liu M; Hu C; Xu Q; Chen L; Ma K; Xu N; Zhu H
    Biosci Rep; 2015 Sep; 35(5):. PubMed ID: 26341629
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Akdemir B; Nakajima Y; Inazawa J; Inoue J
    Mol Cancer Res; 2017 Nov; 15(11):1570-1578. PubMed ID: 28760781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of miR-200a protects cardiomyocytes against hypoxia-induced apoptosis by modulating the kelch-like ECH-associated protein 1-nuclear factor erythroid 2-related factor 2 signaling axis.
    Sun X; Zuo H; Liu C; Yang Y
    Int J Mol Med; 2016 Oct; 38(4):1303-11. PubMed ID: 27573160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperactivity of the transcription factor Nrf2 causes metabolic reprogramming in mouse esophagus.
    Fu J; Xiong Z; Huang C; Li J; Yang W; Han Y; Paiboonrungruan C; Major MB; Chen KN; Kang X; Chen X
    J Biol Chem; 2019 Jan; 294(1):327-340. PubMed ID: 30409900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nrf2 and Keap1 abnormalities in esophageal squamous cell carcinoma and association with the effect of chemoradiotherapy.
    Zhang J; Jiao Q; Kong L; Yu J; Fang A; Li M; Yu J
    Thorac Cancer; 2018 Jun; 9(6):726-735. PubMed ID: 29675925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-200a improves diabetic endothelial dysfunction by targeting KEAP1/NRF2.
    Jiang Z; Wu J; Ma F; Jiang J; Xu L; Du L; Huang W; Wang Z; Jia Y; Lu L; Wu H
    J Endocrinol; 2020 Apr; 245(1):129-140. PubMed ID: 32031966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polydatin prevents fructose-induced liver inflammation and lipid deposition through increasing miR-200a to regulate Keap1/Nrf2 pathway.
    Zhao XJ; Yu HW; Yang YZ; Wu WY; Chen TY; Jia KK; Kang LL; Jiao RQ; Kong LD
    Redox Biol; 2018 Sep; 18():124-137. PubMed ID: 30014902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosome-derived miR-200a promotes esophageal cancer cell proliferation and migration via the mediating Keap1 expression.
    Li P; Liu X; Xing W; Qiu H; Li R; Liu S; Sun H
    Mol Cell Biochem; 2022 Apr; 477(4):1295-1308. PubMed ID: 35137328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of growth hormone in maturation and activation of dendritic cells via miR-200a and the Keap1/Nrf2 pathway.
    Liu QL; Zhang J; Liu X; Gao JY
    Cell Prolif; 2015 Oct; 48(5):573-81. PubMed ID: 26289744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-498 in esophageal squamous cell carcinoma: clinicopathological impacts and functional interactions.
    Islam F; Gopalan V; Law S; Tang JC; Chan KW; Lam AK
    Hum Pathol; 2017 Apr; 62():141-151. PubMed ID: 28188753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PDK1 regulates the progression of esophageal squamous cell carcinoma through metabolic reprogramming.
    Ma Y; Zhang X; Han X; Hao Z; Ji R; Li J; Guo W; Zhang Y; Guan F; Ma S
    Mol Carcinog; 2023 Jun; 62(6):866-881. PubMed ID: 36988347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
    J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of microRNA-200a in bone marrow mesenchymal stem cells enhances the repair of spinal cord injury in rats by reducing oxidative stress and regulating Keap1/Nrf2 pathway.
    Wang X; Ye L; Zhang K; Gao L; Xiao J; Zhang Y
    Artif Organs; 2020 Jul; 44(7):744-752. PubMed ID: 31995644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted therapy of esophageal squamous cell carcinoma: the NRF2 signaling pathway as target.
    Ma S; Paiboonrungruan C; Yan T; Williams KP; Major MB; Chen XL
    Ann N Y Acad Sci; 2018 Dec; 1434(1):164-172. PubMed ID: 29752726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential squamous cell fates elicited by NRF2 gain of function versus KEAP1 loss of function.
    Takahashi J; Suzuki T; Sato M; Nitta S; Yaguchi N; Muta T; Tsuchida K; Suda H; Morita M; Hamada S; Masamune A; Takahashi S; Kamei T; Yamamoto M
    Cell Rep; 2024 Apr; 43(4):114104. PubMed ID: 38602872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.
    Namani A; Matiur Rahaman M; Chen M; Tang X
    BMC Cancer; 2018 Jan; 18(1):46. PubMed ID: 29306329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression Levels of microRNAs miR-93 and miR-200a in Pancreatic Adenocarcinoma with Special Reference to Differentiation and Relapse-Free Survival.
    Karihtala P; Porvari K; Soini Y; Eskelinen M; Juvonen P; Haapasaari KM
    Oncology; 2019; 96(3):164-170. PubMed ID: 30537722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-99a suppresses proliferation, migration and invasion of esophageal squamous cell carcinoma cells through inhibiting the IGF1R signaling pathway.
    Mei LL; Qiu YT; Huang MB; Wang WJ; Bai J; Shi ZZ
    Cancer Biomark; 2017 Dec; 20(4):527-537. PubMed ID: 28800315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C66 ameliorates diabetic nephropathy in mice by both upregulating NRF2 function via increase in miR-200a and inhibiting miR-21.
    Wu H; Kong L; Tan Y; Epstein PN; Zeng J; Gu J; Liang G; Kong M; Chen X; Miao L; Cai L
    Diabetologia; 2016 Jul; 59(7):1558-1568. PubMed ID: 27115417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Krüppel-Like Factor 4 Enhances Sensitivity of Cisplatin to Esophageal Squamous Cell Carcinoma (ESCC) Cells.
    Chen C; Ma Z; Zhang H; Liu X; Yu Z
    Med Sci Monit; 2017 Jul; 23():3353-3359. PubMed ID: 28694421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.